Jakob Dupont
CIK 1553335 · EVP, Head of R&D · last filed 2026-06-11
Jakob Dupont is an EVP, Head of R&D who has filed 49 SEC Form 4 insider transactions across 5 companies since 2019. The most recent filing, for BOLT, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.10M
5
49
-$1.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BOLT | Director | — | $4.56 | — | $0 | 5 | 2026-06-11 |
| PYXS | Director | 38,741 | $1.76 | $68.2K | $0 | 5 | 2026-03-25 |
| ATRA | EVP, Head of R&D | 290,794 | $10.41 | $3.03M | -$573.0K | 15 | 2023-03-06 |
| Apexigen, Inc. (APGNW) Delisted | Director | — | $0.03 | — | $0 | 1 | 2022-10-03 |
| GOSS | Chief Medical Officer | 46,500 | $0.16 | $7.5K | -$631.5K | 3 | 2020-02-19 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2026-03-25 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2025-12-16 | BOLT | Mixed | — | $0 | EDGAR |
| 2025-07-02 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2025-05-05 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2024-09-06 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2024-03-28 | PYXS | Grant (A) | +38,741 | $0 | EDGAR |
| 2023-09-26 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2023-08-25 | PYXS | Grant (A) | — | $0 | EDGAR |